Amanda E. Au
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.
Journal: Nature communications
Published: December 18, 2024
A glycoprotein VI signaling defect in newly formed platelets generated in stress thrombopoiesis.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 25, 2024
Design and characterization of a heterobifunctional degrader of KEAP1.
Journal: Redox biology
Published: September 28, 2022
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors.
Journal: Frontiers in chemistry
Published: January 24, 2022
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.
Journal: The EMBO journal
Published: July 17, 2020
Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 03, 2019
Viral MLKL Homologs Subvert Necroptotic Cell Death by Sequestering Cellular RIPK3.
Journal: Cell reports
Published: November 02, 2018
Altered B-lymphopoiesis in mice with deregulated thrombopoietin signaling.
Journal: Scientific reports
Published: March 27, 2017
Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin.
Journal: PloS one
Published: January 11, 2017
Last Updated: 09/26/2026